{"id":13166,"date":"2023-04-17T14:07:27","date_gmt":"2023-04-17T14:07:27","guid":{"rendered":"http:\/\/lynettelockhart.com\/client\/merck-to-take-10-3\/"},"modified":"2023-04-17T14:08:27","modified_gmt":"2023-04-17T14:08:27","slug":"merck-to-take-10-3","status":"publish","type":"post","link":"http:\/\/lynettelockhart.com\/client\/merck-to-take-10-3\/","title":{"rendered":"Merck to take $10.3 billion R&amp;D charge for Prometheus deal this year"},"content":{"rendered":"<p>(Reuters) &#8211;     Merck &amp; Co expects a research-and-development charge of about $10.3 billion, or $4 per share, this year as the drugmaker accounts its deal for Prometheus Biosciences Inc as an asset acquisition, CFO Caroline Litchfield said.  <\/p>\n<p>The deal is expected to hit Merck&#8217;s profit by 25 cents per share in the first 12 months, Litchfield said in an investor conference call on Monday.     <\/p>\n<p>The deal is expected to close in the third quarter.<\/p>\n<p>Merck on Sunday agreed to buy Prometheus for about $10.8 billion to build up its presence in immunology. Net of Prometheus&#8217; cash balance, the price paid comes to $10.3 billion.<\/p>\n<p \/>\n<p> (Reporting by Raghav Mahobe and Leroy Leo in Bengaluru; Editing by Devika Syammnath)<\/p>\n<p><a href=\"http:\/\/lynettelockhart.com\/client\/merck-to-take-10-3\/file-photo-signage-is-seen-at-the-merck-co-3\/\"><img decoding=\"async\" src=\"http:\/\/lynettelockhart.com\/client\/wp-content\/uploads\/Reuters_Direct_Media\/USOnlineReportBusinessNews\/tagreuters.com2023binary_LYNXMPEJ3G0GB-VIEWIMAGE.jpg\" alt=\"tagreuters.com2023binary_LYNXMPEJ3G0GB-VIEWIMAGE\"><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Reuters) &#8211; Merck &amp; Co expects a research-and-development charge of about $10.3 billion, or $4 per share, this year as the drugmaker accounts its deal for Prometheus Biosciences Inc as an asset acquisition, CFO Caroline Litchfield said. The deal is expected to hit Merck&#8217;s profit by 25 cents per share in the first 12 months, [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":13167,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","footnotes":""},"categories":[1213],"tags":[],"class_list":["post-13166","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-u-s-business"],"jetpack_featured_media_url":"http:\/\/lynettelockhart.com\/client\/wp-content\/uploads\/Reuters_Direct_Media\/USOnlineReportBusinessNews\/tagreuters.com2023binary_LYNXMPEJ3G0GB-VIEWIMAGE.jpg","_links":{"self":[{"href":"http:\/\/lynettelockhart.com\/client\/wp-json\/wp\/v2\/posts\/13166","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/lynettelockhart.com\/client\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/lynettelockhart.com\/client\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/lynettelockhart.com\/client\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"http:\/\/lynettelockhart.com\/client\/wp-json\/wp\/v2\/comments?post=13166"}],"version-history":[{"count":1,"href":"http:\/\/lynettelockhart.com\/client\/wp-json\/wp\/v2\/posts\/13166\/revisions"}],"predecessor-version":[{"id":13168,"href":"http:\/\/lynettelockhart.com\/client\/wp-json\/wp\/v2\/posts\/13166\/revisions\/13168"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/lynettelockhart.com\/client\/wp-json\/wp\/v2\/media\/13167"}],"wp:attachment":[{"href":"http:\/\/lynettelockhart.com\/client\/wp-json\/wp\/v2\/media?parent=13166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/lynettelockhart.com\/client\/wp-json\/wp\/v2\/categories?post=13166"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/lynettelockhart.com\/client\/wp-json\/wp\/v2\/tags?post=13166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}